InMed Pharmaceuticals Inc. (inm) Misses Q2 EPS by 364c
Tweet
Share
E-mailGet Alerts inm Hot Sheet
Join SI Premium – FREE
InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.
For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Penske Automotive Group (PAG) to Equalweight
- UBS Downgrades SFS Group AG (SFSN:SW) (SFSLF) to Neutral
- NVR, Inc. (NVR) Misses Q2 EPS by 701c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
